Pancreatic Cancer Research

ResearcherHiroshima UniversityNo recent work listed

Tomofumi Tsuboi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 4 papers · 2022: 2 papers · 2023: 2 papers

Papers 9

  1. Prognostic factor in patient with recurrent pancreatic adenocarcinoma. Co-author DOI 10.1007/s00423-023-03073-2↗
  2. Utility of Covered Self-Expanding Metal Stents for Biliary Drainage during Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Cancer. Co-author DOI 10.3390/jcm12196245↗
  3. Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer. Co-author DOI 10.1007/s00423-021-02339-x↗
  4. Optimal indication of endoscopic retrograde pancreatography-based cytology in the preoperative pathological diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2022.02.001↗
  5. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarc… Co-author DOI 10.1007/s00261-020-02907-7↗
  6. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer. Co-author DOI 10.1016/j.pan.2021.01.022↗
  7. Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics11020238↗
  8. Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study. Co-author DOI 10.3390/diagnostics11020287↗
  9. Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery. Co-author DOI 10.1155/2016/7968201↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasutaka Ishii · 9 shared papers, 2016–2023 · strength 1.07
  2. Kenichiro Uemura · 6 shared papers, 2016–2023 · strength 0.75
  3. Juri Ikemoto · 5 shared papers, 2021–2023 · strength 0.59
  4. Shinya Nakamura · 4 shared papers, 2021–2023 · strength 0.49
  5. Yoshiaki Murakami · 4 shared papers, 2016–2023 · strength 0.48
  6. Tatsuaki Sumiyoshi · 3 shared papers, 2021–2023 · strength 0.43
  7. Kenjiro Okada · 3 shared papers, 2021–2023 · strength 0.43
  8. Hiroyuki Otsuka · 3 shared papers, 2021–2023 · strength 0.43
  9. Shin’ya Takahashi · 3 shared papers, 2021–2023 · strength 0.43
  10. Ryota Kawamura · 4 shared papers, 2016–2022 · strength 0.39
  11. Kazuaki Chayama · 4 shared papers, 2016–2021 · strength 0.37
  12. Masaru Furukawa · 2 shared papers, 2022–2023 · strength 0.27
  13. Naru Kondo · 2 shared papers, 2021–2022 · strength 0.27
  14. Ryuta Shintakuya · 1 shared paper, 2023 · strength 0.16
  15. Kenta Baba · 1 shared paper, 2023 · strength 0.16
  16. Akinori Shimizu · 2 shared papers, 2016–2021 · strength 0.15
  17. Shiro Oka · 1 shared paper, 2023 · strength 0.15
  18. Hiroshi Aikata · 1 shared paper, 2022 · strength 0.12
  19. Tsuyoshi Sekito · 1 shared paper, 2021 · strength 0.11
  20. Masanobu Yukutake · 1 shared paper, 2021 · strength 0.10
  21. Atsushi Yamaguchi · 1 shared paper, 2021 · strength 0.10
  22. Keiji Hanada · 1 shared paper, 2021 · strength 0.10
  23. Tomoyuki Minami · 1 shared paper, 2021 · strength 0.10
  24. Keisuke Kurihara · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.